Genovate Biotechnology Co., Ltd. (4130)

Profile

https://www.genovate-bio.com

Genovate Biotechnology Co., Ltd. is a Taiwan-based healthcare company focused on the research, development, manufacturing, and sale of pharmaceutical products. The company operates as a fully integrated specialty drug maker, offering both finished dosage forms and active pharmaceutical ingredients. Its product portfolio spans treatments for infectious diseases caused by viruses and bacteria and extends across multiple therapeutic areas, including oncology, cardiovascular conditions, metabolic and alimentary tract disorders, dermatology, musculoskeletal and nervous system diseases, as well as respiratory and urinary system conditions. Genovate Biotechnology also develops controlled-release dosage formulations designed to improve treatment convenience and adherence. Beyond prescription medicines, the company is active in cosmetics and healthcare foods, addressing broader wellness and personal care needs. Serving hospitals, clinics, pharmacies, and other healthcare providers, it plays a meaningful role in Taiwan’s pharmaceutical and biotechnology market. Founded in 1982 and headquartered in Hsinchu, Taiwan, Genovate Biotechnology emphasizes integrated capabilities from R&D through commercial manufacturing to support the availability of specialized therapies and health-related products.